Latest

Letters to the editor Torie Bosch

First Opinion readers on clinical trials in Africa, compounded semaglutide, depressed mice, and more

Health Helen Branswell

Second health care worker tied to Missouri bird flu case had respiratory symptoms

Pharma Rachel Cohrs Zhang

STAT Plus: PhRMA scores a small win in legal challenge to Medicare’s drug price negotiation

Health Helen Branswell

FDA approves first at-home flu vaccine in U.S., a nasal spray

In the Lab Angus Chen

STAT Plus: Q&A: How scientists aim to kill cancers by starving them

Pharma Jason Mast

STAT Plus: FDA approves first drug for rare neuron disease, Niemann-Pick type C

Exclusive Bob Herman

STAT Plus: Amazon cuts ties with fertility benefits company Progyny

Pharmalot Ed Silverman

STAT Plus: FTC sues big 3 PBMs for ‘artificially inflated’ insulin prices caused by ‘perverse’ rebating

Exclusive Lizzy Lawrence

STAT Plus: FDA’s new head of device safety held senior role at company troubled by safety warnings

Biotech Elaine Chen

STAT Plus: Novo’s new obesity drug shows modest results, raises concerns of psychiatric side effects

First Opinion Frances Quee

I’m a pediatrician. My bosses want me to cut new-patient visit times in half

The Readout Meghana Keshavan

Are generalist investors good or bad for biotech?

First Opinion Elizabeth Pfiester

How I fought Big Pharma on insulin prices — and won

Health Isabella Cueto and Theresa Gaffney

Intermittent fasting for teens? Obesity study finds benefits but only under careful supervision

In the Lab Anil Oza

STAT Plus: Research misconduct claims are growing. Will new rules help universities investigate?

Biotech Brittany Trang and Jason Mast

STAT Plus: Ginkgo Bioworks bets on protein AI model and data generation to turn struggling company around

Exclusive John Wilkerson

STAT Plus: Cassidy seeks to exempt small biotechs from Medicare drug price negotiation 

The Readout LOUD Allison DeAngelis, Adam Feuerstein, and Elaine Chen

Cannabinoids for weight loss, a cancelled ad comm, and the Fed lowers interest rates

Pharmalot Ed Silverman

STAT Plus: FDA cites Granules, a large Indian generic drug manufacturer, for tossing truckloads of key documents

Business Aaron Pressman — Boston Globe

STAT Plus: Senate panel votes to hold Steward Health Care CEO in contempt

Pharmalot Ed Silverman

STAT Plus: Lawmakers urge U.S. Patent Office and drugmakers to correct patent mistakes

Health tech Mario Aguilar

Talkspace offers therapy via Amazon, and 23andMe board members resign

The Readout Elaine Chen

The Fed cut rates and biotech stocks… didn’t do much

In the Lab Megan Molteni and Elaine Chen

Long-overlooked scientist shares Lasker Award with other GLP-1 researchers

Biotech Allison DeAngelis

STAT Plus: A new cell therapy company takes its vision from four founders, and its skin from George Church

First Opinion Doug Wirth and Jeffrey S. Crowley

Medicaid must prepare to cover twice-yearly HIV prevention injection

Health Brittany Trang

Q&A: Former NIH director Francis Collins on a Trump administration, science, and God

First Opinion Vonda Vaden Bates

A failing health care system caused my husband’s death

Health tech Lizzy Lawrence

STAT Plus: FDA designates devices for heart surgery, smart knee implant as ‘breakthroughs’